JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): Common genetic etiology yet clinically distinct entities

Blood

Volumn 125, Issue 18, 2015, Pages 2753-2758

  Calvo, Katherine R ^a   Price, Susan ^b   Braylan, Raul C ^a   Oliveira, Joao Bosco ^c   Lenardo, Michael ^b   Fleisher, Thomas A ^a   Rao, Koneti V ^b  

^a Blood Services Section   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW; CELL STRUCTURE; CHRONIC MYELOMONOCYTIC LEUKEMIA; DISEASE COURSE; GRANULOCYTE; HUMAN; IMMUNOPHENOTYPING; JUVENILE MYELOMONOCYTIC LEUKEMIA; MONOCYTE; ONCOGENE N RAS; ONCOGENE RAS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAS ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; ADOLESCENT; ADULT; CHILD; FEMALE; GENETICS; LEUKOCYTOSIS; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, RAS; HUMANS; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; LEUKOCYTOSIS; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 84928806465     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-11-567917     Document Type: Article

References (39)

1. Oliveira JB, Bidére N, Niemela JE, et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104(21):8953-8958.
2. Niemela JE, Lu L, Fleisher TA, et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood. 2011; 117(10):2883-2886.
3. Takagi M, Shinoda K, Piao J, et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood. 2011;117(10): 2887-2890.
4. Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):e35-e40.
5. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999; 93(2):459-466.
6. Chang TY, Dvorak CC, Loh ML. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia. Blood. 2014;124(16):2487-2497.
7. Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015;125(7): 1083-1090.
8. Van Etten RA, Shannon KM. Focus on myeloproliferative diseases and myelodysplastic syndromes. Cancer Cell. 2004;6(6):547-552.
9. Stephen AG, Esposito D, Bagni RK, McCormick F. Dragging ras back in the ring. Cancer Cell. 2014;25(3):272-281.
10. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3(6): 459-465.
11. Teodorovic LS, Babolin C, Rowland SL, et al. Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies. Proc Natl Acad Sci USA. 2014;111(27):E2797-E2806.
12. Pierpont ME, Magoulas PL, Adi S, et al. Cardiofacio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2014;134(4):e1149-e1162.
13. Cizmarova M, Kostalova L, Pribilincova Z, et al. Rasopathies-dysmorphic syndromes with short stature and risk of malignancy. Endocr Regul. 2013;47(4):217-222.
14. Niemeyer CM. RAS diseases in children. Haematologica. 2014;99(11):1653-1662.
15. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood. 1994;83(8):2248-2254.
16. Niemeyer CM, Kratz CP. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol. 2008;140(6):610-624.
17. Loh ML, Vattikuti S, Schubbert S, et al. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood. 2004;103(6):2325-2331.
18. Loh ML, Sakai DS, Flotho C, et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood. 2009;114(9):1859-1863.
19. Sugimoto Y, Muramatsu H, Makishima H, et al. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. Br J Haematol. 2010;150(1):83-87.
20. Gratias EJ, Liu YL, Meleth S, Castleberry RP, Emanuel PD. Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2005;44(2): 142-146.
21. Xu GF, Lin B, Tanaka K, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell. 1990;63(4): 835-841.
22. Tartaglia M, Kalidas K, Shaw A, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70(6):1555-1563.
23. Sakaguchi H, Okuno Y, Muramatsu H, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013; 45(8):937-941.
24. Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res. 2009;33(3):355-362.
25. Dvorak CC, Loh ML. Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation. Front Pediatr. 2014;2:25.
26. Lanzarotti N, Bruneau J, Trinquand A, et al. RASassociated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia. Blood. 2014;123(12):1960-1963.
27. Matsuda K, Shimada A, Yoshida N, et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood. 2007;109(12):5477-5480.
28. Doisaki S, Muramatsu H, Shimada A, et al. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia. Blood. 2012;120(7):1485-1488.
29. Kussick SJ, Fromm JR, Rossini A, et al. Fourcolor flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol. 2005;124(2):170-181.
30. Westers TM, Ireland R, Kern W, et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia. 2012; 26(7):1730-1741.
31. Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015;125(1):56-70.
32. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74-e80.
33. Ziegler-Heitbrock HW, Fingerle G, Ströbel M, et al. The novel subset of CD141/CD161 blood monocytes exhibits features of tissue macrophages. Eur J Immunol. 1993;23(9): 2053-2058.
34. Fingerle G, Pforte A, Passlick B, Blumenstein M, Ströbel M, Ziegler-Heitbrock HW. The novel subset of CD141/CD161 blood monocytes is expanded in sepsis patients. Blood. 1993;82(10): 3170-3176.
35. Takagi M, Piao J, Lin L, et al. Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML. Leukemia. 2013;27(9):1926-1928.
36. Maschan M, Bobrynina V, Khachatryan L, et al. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation. Pediatr Blood Cancer. 2014;61(10): 1871-1873.
37. Maschan AA, Khachatrian LA, Solopova GG, et al. Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol. 2011;33(1):e32-e34.
38. Matsuda K, Yoshida N, Miura S, et al. Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations. Br J Haematol. 2012;157(5):647-650.
39. Niemeyer CM, Arico M, Basso G, et al; European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood. 1997;89(10):3534-3543.